CAR T-Cell Therapy in Oncology: The Crucial Role of Advanced Practice Nurses

Strategic Insights -

The landscape of cancer treatment is rapidly evolving with the emergence of chimeric antigen receptor (CAR) T-cell therapy, a cutting-edge approach that holds promise for patients with certain types of cancer. Researchers at the City of Hope National Medical Center have highlighted the importance of advanced practice nurses (APNs) in ensuring safe and coordinated care for patients undergoing CAR T-cell therapy in outpatient settings.

Key Takeaways:

  • CAR T-cell therapy represents a transformative approach in oncology, offering a new hope for patients with certain types of cancer.
  • Advanced practice nurses (APNs) play a vital role in ensuring safe and coordinated care during and after treatment, particularly in outpatient settings.
  • A practical primer for non-oncology APNs has been developed to equip them with foundational knowledge on CAR T-cell therapy's mechanisms, logistics, toxicities, and long-term considerations.
  • The article emphasizes early recognition, collaborative care, and patient education to strengthen APNs' confidence and competence in co-managing this high-risk population.
  • As the landscape of cellular therapy evolves, equipping APNs with foundational knowledge is critical for enhancing survivorship and reducing preventable complications.
  • The City of Hope National Medical Center's Immune Effector Cell Therapy Program has been at the forefront of research and development in this area, with a focus on improving patient outcomes.

Statistics:

  • CAR T-cell therapy has been increasingly being administered in outpatient settings, highlighting the importance of community-based care.
  • The Journal for Nurse Practitioners has published a primer on CAR T-cell therapy for community-based APNs, aiming to strengthen their confidence and competence in co-managing this high-risk population.
  • According to the City of Hope National Medical Center, equipping APNs with foundational knowledge is critical for enhancing survivorship and reducing preventable complications.
  • CAR T-cell therapy represents a cuttting-edge approach in oncology, with many patients experiencing significant positive outcomes.

Sources:

  • Uniting Advanced Practice Nurses for Better Cancer Care: a Primer On Chimeric Antigen Receptor T-cell Therapy for Community-based Apns. The Journal for Nurse Practitioners, 2025;21(10).
  • City of Hope National Medical Center, Immune Effector Cell Therapy Program.
  • NewsRx. New Cancer Findings Has Been Reported by Investigators at City of Hope National Medical Center (Uniting Advanced Practice Nurses for Better Cancer Care: a Primer On Chimeric Antigen Receptor T-cell Therapy for Community-based Apns). Cancer Weekly. November 4, 2025; p 327.